查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439544

血管支架-全球市場回顧、競爭格局、市場預測（2030年）

Vascular Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

預計2023年全球血管支架市場規模將達到133.1億美元，到2030年將達到210.1億美元，2024-2030年預測期內複合年增長率為7.90%。 血管支架需求的增加主要是由於動脈粥狀硬化、頸動脈疾病和周邊動脈疾病等血管疾病的盛行率不斷增加。 此外，患者群體對微創手術的日益偏好、產品領域的技術進步、各種血管支架的批准等都是未來幾年全球血管支架市場的驅動因素。

血管支架市場動態

由於世界各地人們各種血管疾病的負擔日益增加，血管支架市場目前正在蓬勃發展。 血管病症或血管疾病包括影響血管的任何病症。 週邊動脈疾病（PAD）、頸動脈疾病、冠狀動脈疾病和中風是世界人口中一些較常見的血管疾病。 例如，根據世界中風組織（WSO）2019年揭露的消息，全球有超過8,000萬人經歷中風。

另外，根據澳洲政府2022年的數據，2018年該國報告了約38,600例中風，2017-2018年約6.2%的澳洲成年人患有心臟病或中風一種或多種疾病或血管疾病疾病。 世界其他國家也可能出現類似的趨勢。 因此，全球各種血管疾病負擔的增加預計將增加對血管支架的需求，從而促進全球血管支架市場在預測期內的成長。

此外，患者對微創手術的日益偏好也預計將推動血管支架的需求。 這是因為與搭橋手術相比，球囊血管成形術和血管支架置入術的侵入性要小得多，風險相對較低且成本較低。

此外，公司對血管支架產品的報銷將增加患者群體對血管支架的採用，從而有可能在未來幾年擴大血管支架市場。 例如，2020年6月，印度冠狀動脈支架市場領導者SMT（Sahajanand Medical Technologies Pvt Ltd）收到了法國衛生和公共事務部對Supraflex和Supraflex Cruz的全額報銷確認。

因此，所有上述因素可能會交織在一起，在未來幾年推動血管支架市場的發展。

然而，與血管支架相關的風險以及產品嚴格的監管審批流程可能會抑制市場成長。

此外，史無前例的 COVID-19 大流行減緩了全球血管支架市場的早期發展。 全國範圍內的封鎖、為防止感染傳播而取消或拒絕擇期手術以及跨境物流限制導致的供應鏈中斷是導致血管支架市場增長緩慢的部分原因。 然而，由於2020年下半年全球眾多COVID-19疫苗的批准和管理，包括醫療服務在內的各個領域的活動恢復情況有了顯著改善，從而促進了全球健康增長血管支架市場復甦之路已開啟。

血管支架細分市場分析

在血管支架類型領域，藥物洗脫支架預計將在未來幾年佔據主要市場份額。 與藥物洗脫支架相關的主要優點是，與穩定冠心病患者的裸金屬支架 (BMS) 相比，這些支架可以有效降低經皮冠狀動脈介入治療 (PCI) 後支架內再狹窄率。 多項研究已證明，與 BMS 相比，藥物洗脫支架 (DES) 可將原生冠狀動脈病變的再狹窄率降低 70% 以上。 因此，現在認為外科醫生更願意在PCI手術期間放置DES，增加了對DES血管支架的需求。

本報告研究和分析了全球血管支架市場，提供市場規模和預測、驅動因素和挑戰、公司和產品概況等。

目錄

第1章血管支架市場報告簡介

第2章血管支架市場摘要

  • 調查範圍
  • 市場概覽
  • 競爭評估
  • 財務基準

第3章監理與專利分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第4章血管支架市場主要因素分析

  • 血管支架市場驅動因素
    • 全世界各種血管疾病的盛行率不斷上升
    • 對微創手術的偏好日益增加
    • 血管支架技術進展及發布
    • 人口老化負擔日益加重
  • 血管支架市場限制與挑戰
    • 與血管支架相關的風險和併發症
    • 嚴格的監理審批流程
  • 血管支架市場機遇
    • 中低收入國家血管支架市場面臨重大機會
    • 生物可吸收血管支架的機會

第5章血管支架波特五力分析

第6章COVID-19對血管支架市場的影響分析

第7章血管支架市場佈局

  • 依產品類型
    • 冠狀動脈支架
    • 週邊血管支架
    • EVAR 覆膜支架
  • 依類型
    • 裸金屬支架
    • 藥物洗脫支架
  • 依材質
    • 金屬
    • 聚合物
  • 依交付方式
    • 球囊擴張支架
    • 自膨脹支架
  • 按最終用戶
    • 醫院
    • 門診手術中心
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他領域

第 8 章血管支架：全球公司份額分析 - 3 至 5 家主要公司

第9章血管支架公司及產品簡介

  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • BIOTRONIK SE & Co. KG
  • B. Braun Melsungen AG
  • Terumo Corporation
  • eucatech AG
  • MicroPort Scientific Corporation
  • Meril Life Sciences Pvt. Ltd
  • Vascular Concepts (SMT)
  • W. L. Gore & Associates, Inc.
  • Becton, Dickinson and Company.
  • ENDOLOGIX LLC.
  • Biosensors International Group, Ltd.
  • Lombard Medical
  • Translumina GmbH
  • JOTEC GmbH
  • iVascular
  • Cordis
  • Cook

第10章KOL觀看次數

第 11 章專案方法

第 12 章關於 DelveInsight

第 13 章免責聲明與聯絡我們

Product Code: DIMDCL0369

Vascular Stents Market By Product Type (Coronary Stents, Peripheral Stents [Carotid Stents, Iliac Stents, Femoral Stents, Femoral Stents, Other], Evar Stent Grafts [Abdominal Aortic Aneurysm Stents, Thoracic Aortic Aneurysm Stents]), By Type (Bare-Metal Stents, Drug-Eluting Stents), By Material (Metal And Polymer), By Mode Of Delivery (Balloon-Expandable Stents And Self Expandable Stents), By End-User (Hospitals And Ambulatory Surgical Centers), by geography, is expected to grow at a noteworthy CAGR forecast till 2030 owing to rising burden of vascular diseases across the globe and increasing preferences of minimally invasive surgeries among the patient population

The global vascular stents market was valued at USD 13.31 billion in 2023, growing at a CAGR of 7.90% during the forecast period from 2024 to 2030, to reach USD 21.01 billion by 2030. The increase in demand for vascular stents is predominantly attributed to the growing prevalence of vascular disorders such as atherosclerosis, carotid artery diseases, and peripheral artery diseases, among others. In addition, growing preferences for minimally invasive surgeries among the patient population, growing technological advancement in the product arena, and approval of various vascular stents, among others are some of the factors responsible for driving the global vascular stents market in the forthcoming years.

Vascular Stents Market Dynamics:

The market for vascular stents is gathering momentum at present owing to the rising burden of various vascular disorders among the population across the globe. Vascular disorders or diseases include any condition that affects the blood vessels. Peripheral artery diseases (PAD), carotid artery diseases, coronary artery diseases, stroke are some of the types of vascular disorders which are more prevalent among the worldwide population. For instance, according to the facts revealed by the World Stroke Organization (WSO) in the year 2019, globally, over 80 million people were living who have experienced a stroke.

In addition, as per the Australian Government 2022 data, approximately 38,600 strokes were reported in the country in the year 2018 and about 6.2% of Australian adults (1.2 million) had one or more conditions related to heart, stroke, or vascular diseases in 2017-18. Similar trends are likely to observe in other countries across the globe. Thus, the rising burden of various vascular diseases worldwide is expected to increase the demand for vascular stents thereby augmenting the global vascular stents market growth during the forecast period.

Moreover, rising preferences for minimally invasive surgeries among patients are also anticipated to raise the demand for vascular stents. This is because as compared to bypass surgery, balloon angioplasty and vascular stent placement are much less invasive and relatively low-risk, low-cost procedures.

Additionally, companies receiving reimbursement for their vascular stents products could also increase the market of these devices in the upcoming years as it will raise the adoption of these devices among the patient pool. For instance, in June 2020, SMT (Sahajanand Medical Technologies Pvt Ltd), the Indian market leader in coronary heart stent received the full reimbursement confirmation for its Supraflex and Supraflex Cruz from the Ministry of Health and Public Affairs of France.

Thus, the interplay of all the above-mentioned factors is likely to boost the vascular stents market in the forthcoming years.

However, the risk associated with vascular stents and the stringent regulatory approval process of the product is likely to impede the market growth.

In addition, the unprecedented COVID-19 outbreak has slowed down the global market for Vascular Stents during the initial phases. Nationwide lockdown, canceled or denied elective surgeries to prevent the transmission of the infection, disruptive supply chain due to logistical restriction across the border are some of the reasons that lead to the sluggish market growth of vascular stents. However, owing to the approval and administration of numerous COVID-19 vaccines across the globe in the second half of 2020, there was a significant improvement in the resumption of activities across various domains including healthcare services, thereby paving the way for a sound period of recovery for the vascular stents market.

Vascular Stents Market Segment Analysis:

Vascular Stents Market By Product Type (Coronary Stents, Peripheral Stents [Carotid Stents, Iliac Stents, Femoral Stents, Femoral Stents, Other], EVAR Stent Grafts [Abdominal Aortic Aneurysm Stents, Thoracic Aortic Aneurysm Stents]), By Type (Bare Metal Stents, Drug-Eluting Stents), By Material (Metal And Polymer), By Mode Of Delivery (Balloon Expandable Stents and Self Expandable Stents), By End-User (Hospitals and Ambulatory Surgical Centers), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the Vascular Stents type segment, the drug-eluting stents are expected to hold a significant market share during the forthcoming years. The main advantage associated with the drug-eluting stents is that these stents are efficient in reducing the rates of in-stent restenosis after percutaneous coronary intervention (PCI) compared to bare-metal stents (BMS) in stable coronary artery disease. Various researches have demonstrated that Drug-eluting stents (DES) reduce the rate of restenosis by over 70% compared to BMS in native coronary lesions. Thus, at present the DES placement is believed to be preferred by the surgeon during PCI surgery, thereby increasing the demand for the DES vascular stents.

Moreover, the rise in research and development activities by the manufacturers actively developing vascular stents in the market to bring new products in the upcoming years is also expected to fuel the segmental market of vascular stents. For instance, Abbott in June 2020, initiated a clinical trial for its next-generation drug-eluting stent 48mm Study (SPIRIT 48). The purpose of the study is to evaluate the safety and effectiveness of the ABT NG DES 48 in improving coronary artery luminal diameter in subjects with coronary artery disease (CAD) due to de novo native coronary artery long lesions. Moreover, this clinical investigation will be conducted under an investigational device exemption (IDE) and is intended to support market approval of the ABT NG DES 48 in the United States. The study is expected to get complete by November 2022.

Additionally, approval of various vascular stents at present could also contribute to the segmental market growth. For instance, on October 16, 2020, Biosensors International Group Ltd (Biosensors) was granted a CE Mark for BioFreedom(TM) Ultra, their new drug-coated coronary stent system.

Hence, all the aforementioned factors are projected to drive the segmental growth of the vascular stent market in the forthcoming years.

North America is expected to dominate the overall Vascular Stents Market:

Among all the regions, North America is expected to occupy a major share in the overall vascular stents market during the forecasted period. This is owing to the rising obesity levels, rising hypertension among the population, increase in alcohol consumption, and smoking which often leads to various cardiovascular disorders such as coronary heart and peripheral vascular disorders which require vascular stenting as a treatment. In addition, the growing geriatric population, rapid technological advancements coupled with the increasing healthcare expenditures in the region have spurred the demand for vascular stents.

Further, in the US, as per the report published by the Centers for Disease Control and Prevention in the year 2023, approximately 6.5 million people age 40 and older in the US have Peripheral Artery Diseases (PAD) in the same year.

Also, as per the above-mentioned source, the US obesity prevalence was 42.4% in 2017 - 2018 which tremendously increased from the last decade when it was 30.5% of the total US population. Through various researches, it has been concluded that obesity has an important role in atherosclerosis and coronary artery disease.

Moreover, the presence of key market players and their strategic business activities such as collaboration, approval, and launch of the product, among others are likely to bolster the regional vascular stent market in the upcoming years. For instance, in October 2020, Medtronic received approval from the US Food and Drug Administration (FDA) for its Abre Venous Self-expanding Stent System to treat deep venous obstruction, a medical condition that may limit blood flow from the leg and lead to swelling of the leg and pain when walking.

Hence, the interplay of all the above-mentioned factors is projected to spur the vascular stents market in the region during the forecasted period.

Furthermore, the Asia-Pacific region has the future potential growth for the global vascular stents market. The adoption of a sedentary lifestyle among the population which significantly increases the risk of coronary heart disease, and other vascular disorders is the key driving factor for the vascular stents market. In addition, the rising geriatric population in the region, improving healthcare infrastructure, and rise in disposable income, among others, are some of the factors which make the APAC region the fastest growing market for vascular stents during the forecasted period.

Vascular Stents Market Key Players:

Some of the key market players operating in the Vascular Stents market include Medtronic, Abbott, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, eucatech AG, MicroPort Scientific Corporation., Meril Life Sciences Pvt. Ltd., Vascular Concepts (SMT), W. L. Gore & Associates, Inc., Becton, Dickinson and Company., ENDOLOGIX LLC., Biosensors International Group, Ltd., Lombard Medical, Translumina GmbH, JOTEC GmbH, iVascular, Cordis, Cook, SCITECH, and others.

Recent Developmental Activities in the Vascular Stents Market:

In August 2020, Boston Scientific Corporation received FDA approval for SYNERGY(TM) Everolimus-Eluting Platinum Chromium Coronary Stent System (Monorail(TM)), SYNERGY(TM) Everolimus-Eluting Platinum Chromium Coronary Stent System (Over-The-Wire(TM)), and SYNERGY(TM) XD Everolimus-Eluting Platinum Chromium Coronary Stent System (Monorail(TM)) is indicated for use in patients who have a narrowing in their coronary arteries and are at high risk for bleeding.

In July 2020, INSPIRON Coronary Sirolimus-Eluting Stent from SCITECH Medical received CE Mark approval.

In May 2020, SMT (Sahajanand Medical Technologies Pvt. Ltd) acquired the structural heart medical device firm Vascular Concepts, providing cutting-edge medical devices for the treatment of arterial diseases.

Key Takeaways from the Vascular Stents Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Vascular Stents market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Vascular Stents Market.

Various opportunities available for the other competitor in the Vascular Stents Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Vascular Stents market growth in the coming future?

Target Audience who can be benefited from the Vascular Stents Market Report Study

Vascular Stents providers

Research organizations and consulting companies

Vascular Stents-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Vascular Stents

Various End-users who want to know more about the Vascular Stents Market and the latest technological developments in the Vascular Stents market.

Frequently Asked Questions for the Vascular Stents Market:

1. What are Vascular Stents?

Vascular stents are small tubular scaffolds widely used in the treatment of narrowing of the vessel to prevent acute vessel closure and late restenosis in a variety of vessels such as coronary arteries.

2. What is the market for Global Vascular Stents?

The global vascular stents market was valued at USD 13.31 billion in 2023, growing at a CAGR of 7.90% during the forecast period from 2024 to 2030, to reach USD 21.01 billion by 2030.

3. What are the drivers for the Global Vascular Stents?

The major factor driving the demand for Vascular Stents is the growing prevalence of vascular disorders such as atherosclerosis, carotid artery diseases, and peripheral artery diseases, among others. Moreover, rising preferences for minimally invasive surgeries among the patient population, increasing technological advancement in the product arena, and approval of various vascular stents, among others are some of the factors responsible for driving the global vascular stents market in the forthcoming years.

4. What are the key players operating in Global Vascular Stents?

Some of the key market players operating in the Vascular Stents market include Medtronic, Abbott, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, eucatech AG, MicroPort Scientific Corporation., Meril Life Sciences Pvt. Ltd., Vascular Concepts (SMT), W. L. Gore & Associates, Inc., Becton, Dickinson and Company., ENDOLOGIX LLC., Biosensors International Group, Ltd., Lombard Medical, Translumina GmbH, JOTEC GmbH, iVascular, Cordis, Cook, and others.

5. Which region has the highest share in the Vascular Stents market?

Among all the regions, North America is expected to occupy a major share in the overall vascular stents market during the forecast period, 2024-2030. This is owing to the rising obesity levels, rising hypertension among the population, increase in alcohol consumption, and smoking which often leads to various cardiovascular disorders such as coronary heart and peripheral vascular disorders which require vascular stenting as a treatment. In addition, the growing geriatric populations, rapid technological advancements coupled with the increasing healthcare expenditures in the region have spurred the demand for vascular stents.

Table of Contents

1.Vascular Stents Market Report Introduction

2.Vascular Stents Market Executive summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Vascular Stents Market Key factors analysis

  • 4.1. Vascular Stents Market Drivers
    • 4.1.1. The rising prevalence of various vascular disorders among the population, worldwide
    • 4.1.2. The growing preferences for minimally invasive surgeries
    • 4.1.3. Technological advancement and launches of vascular stents
    • 4.1.4. The rising burden of the geriatric population
  • 4.2. Vascular Stents Market Restraints and Challenges
    • 4.2.1. Risk and complications associated with vascular stents
    • 4.2.2. The stringent regulatory approval process
  • 4.3. Vascular Stents Market Opportunities
    • 4.3.1. Low and middle-income nations have tremendous opportunities for the Vascular Stents market
    • 4.3.2. Opportunities for bioresorbable vascular scaffolds

5. Vascular Stents Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Vascular Stents Market

7. Vascular Stents Market layout

  • 7.1. By Product Type
    • 7.1.1. Coronary Stents
    • 7.1.2. Peripheral Stents
      • 7.1.2.1. Carotid Stents
      • 7.1.2.2. Renal Artery Stents
      • 7.1.2.3. Femoral Stents
      • 7.1.2.4. Iliac Stents
      • 7.1.2.5. Other Peripheral stents
    • 7.1.3. EVAR Stent Grafts
      • 7.1.3.1. Abdominal Aortic Aneurysm Stents
      • 7.1.3.2. Thoracic Aortic Aneurysm Stents
  • 7.2. By Type
    • 7.2.1. Bare-metal Stents
    • 7.2.2. Drug-eluting Stents
  • 7.3. By Material
    • 7.3.1. Metal
    • 7.3.2. Polymer
  • 7.4. By Mode of Delivery
    • 7.4.1. Balloon-expandable Stents
    • 7.4.2. Self-expanding Stents
  • 7.5. By End-user
    • 7.5.1. Hospitals
    • 7.5.2. Ambulatory Surgical Centers
  • 7.6. By Geography
    • 7.6.1. North America
      • 7.6.1.1. North America Vascular Stents Market, by Product Type
      • 7.6.1.2. North America Vascular Stents Market, by Type
      • 7.6.1.3. North America Vascular Stents Market, by Material
      • 7.6.1.4. North America Vascular Stents Market, by Mode of Delivery
      • 7.6.1.5. North America Vascular Stents Market, by End User
      • 7.6.1.6. North America Vascular Stents Market, by Country
      • 7.6.1.6.1. United States
      • 7.6.1.6.2. Canada
      • 7.6.1.6.3. Mexico
    • 7.6.2. Europe
      • 7.6.2.1. Europe Vascular Stents Market, by Product Type
      • 7.6.2.2. Europe Vascular Stents Market, by Type
      • 7.6.2.3. Europe Vascular Stents Market, by Material
      • 7.6.2.4. Europe Vascular Stents Market, by Mode of Delivery
      • 7.6.2.5. Europe Vascular Stents Market, by End User
      • 7.6.2.6. Europe Vascular Stents Market, by Country
      • 7.6.2.6.1. France
      • 7.6.2.6.2. Germany
      • 7.6.2.6.3. United Kingdom
      • 7.6.2.6.4. Italy
      • 7.6.2.6.5. Spain
      • 7.6.2.6.6. Russia
      • 7.6.2.6.7. Rest of Europe
    • 7.6.3. Asia-Pacific
      • 7.6.3.1. Asia-Pacific Vascular Stents Market, by Product Type
      • 7.6.3.2. Asia-pacific Vascular Stents Market, by Type
      • 7.6.3.3. Asia-Pacific Vascular Stents Market, by Material
      • 7.6.3.4. Asia-Pacific Vascular Stents Market, by Mode of Delivery
      • 7.6.3.5. Asia-Pacific Vascular Stents Market, by End User
      • 7.6.3.6. Asia-Pacific Vascular Stents Market, by Country
      • 7.6.3.6.1. China
      • 7.6.3.6.2. Japan
      • 7.6.3.6.3. India
      • 7.6.3.6.4. Australia
      • 7.6.3.6.5. South Korea
      • 7.6.3.6.6. Rest of Asia Pacific
    • 7.6.4. Rest of the World (RoW)
      • 7.6.4.1. RoW Vascular Stents Market, by Product Type
      • 7.6.1.2. RoW Vascular Stents Market, by Type
      • 7.6.1.3. RoW Vascular Stents Market, by Material
      • 7.6.4.4. RoW Vascular Stents Market, by Mode of Delivery
      • 7.6.4.5. RoW Vascular Stents Market, by End User
      • 7.6.4.6. RoW Vascular Stents Market, by Region
      • 7.6.4.6.1. Middle East
      • 7.6.4.6.2. Africa
      • 7.6.4.6.3. South America

8. Vascular Stents Global Company Share Analysis - Key 3-5 Companies

9. Vascular Stents Company and Product Profiles

  • 9.1. Medtronic
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. Abbott
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Boston Scientific Corporation
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. BIOTRONIK SE & Co. KG
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. B. Braun Melsungen AG
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. Terumo Corporation
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. eucatech AG
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. MicroPort Scientific Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. Meril Life Sciences Pvt. Ltd
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Vascular Concepts (SMT)
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. W. L. Gore & Associates, Inc.
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Becton, Dickinson and Company.
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. ENDOLOGIX LLC.
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. Biosensors International Group, Ltd.
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. Lombard Medical
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. Translumina GmbH
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17. JOTEC GmbH
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18. iVascular
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy
  • 9.19. Cordis
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4. Product Listing
    • 9.19.5. Entropy
  • 9.20. Cook
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4. Product Listing
    • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis on Vascular Stents Market
  • Table 3: Vascular Stents Market Analysis in Global (2021-2030)
  • Table 4: Vascular Stents Market Analysis in Global by Product Type (2021-2030)
  • Table 5: Vascular Stents Market Analysis in Global by Type (2021-2030)
  • Table 6: Vascular Stents Market Analysis in Global by Material (2021-2030)
  • Table 7: Vascular Stents Market Analysis in Global by Mode of Delivery (2021-2030)
  • Table 8: Vascular Stents Market Analysis in Global by End User (2021-2030)
  • Table 9: Vascular Stents Market Analysis in Global by Geography (2021-2030)
  • Table 10: Vascular Stents Market Analysis in North America (2021-2030)
  • Table 11: Vascular Stents Market Analysis in North America by Product Type (2021-2030)
  • Table 12: Vascular Stents Market Analysis in North America by Type (2021-2030)
  • Table 13: Vascular Stents Market Analysis in North America by Material (2021-2030)
  • Table 14: Vascular Stents Market Analysis in North America by Mode of Delivery (2021-2030)
  • Table 15: Vascular Stents Market Analysis in North America by End User (2021-2030)
  • Table 16: Vascular Stents Market Analysis in North America by Country (2021-2030)
  • Table 17: Vascular Stents Market Analysis in the US (2021-2030)
  • Table 18: Vascular Stents Market Analysis in Canada (2021-2030)
  • Table 19: Vascular Stents Market Analysis in Mexico (2021-2030)
  • Table 20: Vascular Stents Market Analysis in Europe (2021-2030)
  • Table 21: Vascular Stents Market Analysis in Europe by Product Type (2021-2030)
  • Table 22: Vascular Stents Market Analysis in Europe by Type (2021-2030)
  • Table 23: Vascular Stents Market Analysis in Europe by Material (2021-2030)
  • Table 24: Vascular Stents Market Analysis in Europe by Mode of Delivery (2021-2030)
  • Table 25: Vascular Stents Market Analysis in Europe by End User (2021-2030)
  • Table 26: Vascular Stents Market Analysis in Europe by Country (2021-2030)
  • Table 27: Vascular Stents Market Analysis in France (2021-2030)
  • Table 28: Vascular Stents Market Analysis in Germany (2021-2030)
  • Table 29: Vascular Stents Market Analysis in the UK (2021-2030)
  • Table 30: Vascular Stents Market Analysis in Italy (2021-2030)
  • Table 31: Vascular Stents Market Analysis in Spain (2021-2030)
  • Table 32: Vascular Stents Market Analysis in Russia (2021-2030)
  • Table 33: Vascular Stents Market Analysis in Rest of Europe (2021-2030)
  • Table 34: Vascular Stents Market Analysis in Asia-Pacific (2021-2030)
  • Table 35: Vascular Stents Market Analysis in Asia-Pacific by Product Type (2021-2030)
  • Table 36: Vascular Stents Market Analysis in Asia-Pacific by Type (2021-2030)
  • Table 37: Vascular Stents Market Analysis in Asia-Pacific by Material (2021-2030)
  • Table 38: Vascular Stents Market Analysis in Asia-Pacific by Mode of Delivery (2021-2030)
  • Table 39: Vascular Stents Market Analysis in Asia-Pacific by End User (2021-2030)
  • Table 40: Vascular Stents Market Analysis in Asia-Pacific by Country (2021-2030)
  • Table 41: Vascular Stents Market Analysis in China (2021-2030)
  • Table 42: Vascular Stents Market Analysis in Japan (2021-2030)
  • Table 43: Vascular Stents Market Analysis in India (2021-2030)
  • Table 44: Vascular Stents Market Analysis in Australia (2021-2030)
  • Table 45: Vascular Stents Market Analysis in South Korea (2021-2030)
  • Table 46: Vascular Stents Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Table 47: Vascular Stents Market Analysis in Rest of World (2021-2030)
  • Table 48: Vascular Stents Market Analysis in Rest of World by Product Type (2021-2030)
  • Table 49: Vascular Stents Market Analysis in Rest of World by Type (2021-2030)
  • Table 50: Vascular Stents Market Analysis in Rest of World by Material (2021-2030)
  • Table 51: Vascular Stents Market Analysis in Rest of World by Mode of Delivery (2021-2030)
  • Table 52: Vascular Stents Market Analysis in Rest of World by End User (2021-2030)
  • Table 53: Vascular Stents Market Analysis in Rest of World by Country (2021-2030)
  • Table 54: Vascular Stents Market Analysis in the Middle East (2021-2030)
  • Table 55: Vascular Stents Market Analysis in Africa (2021-2030)
  • Table 56: Vascular Stents Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis on Vascular Stents Market
  • Figure 3: Vascular Stents Market Analysis in Global (2021-2030)
  • Figure 4: Vascular Stents Market Analysis in Global by Product Type (2021-2030)
  • Figure 5: Vascular Stents Market Analysis in Global by Type (2021-2030)
  • Figure 6: Vascular Stents Market Analysis in Global by Material (2021-2030)
  • Figure 7: Vascular Stents Market Analysis in Global by Mode of Delivery (2021-2030)
  • Figure 8: Vascular Stents Market Analysis in Global by End User (2021-2030)
  • Figure 9: Vascular Stents Market Analysis in Global by Geography (2021-2030)
  • Figure 10: Vascular Stents Market Analysis in North America (2021-2030)
  • Figure 11: Vascular Stents Market Analysis in North America by Product Type (2021-2030)
  • Figure 12: Vascular Stents Market Analysis in North America by Type (2021-2030)
  • Figure 13: Vascular Stents Market Analysis in North America by Material (2021-2030)
  • Figure 14: Vascular Stents Market Analysis in North America by Mode of Delivery (2021-2030)
  • Figure 15: Vascular Stents Market Analysis in North America by End User (2021-2030)
  • Figure 16: Vascular Stents Market Analysis in North America by Country (2021-2030)
  • Figure 17: Vascular Stents Market Analysis in the US (2021-2030)
  • Figure 18: Vascular Stents Market Analysis in Canada (2021-2030)
  • Figure 19: Vascular Stents Market Analysis in Mexico (2021-2030)
  • Figure 20: Vascular Stents Market Analysis in Europe (2021-2030)
  • Figure 21: Vascular Stents Market Analysis in Europe by Product Type (2021-2030)
  • Figure 22: Vascular Stents Market Analysis in Europe by Type (2021-2030)
  • Figure 23: Vascular Stents Market Analysis in Europe by Material (2021-2030)
  • Figure 24: Vascular Stents Market Analysis in Europe by Mode of Delivery (2021-2030)
  • Figure 25: Vascular Stents Market Analysis in Europe by End User (2021-2030)
  • Figure 26: Vascular Stents Market Analysis in Europe by Country (2021-2030)
  • Figure 27: Vascular Stents Market Analysis in France (2021-2030)
  • Figure 28: Vascular Stents Market Analysis in Germany (2021-2030)
  • Figure 29: Vascular Stents Market Analysis in the UK (2021-2030)
  • Figure 30: Vascular Stents Market Analysis in Italy (2021-2030)
  • Figure 31: Vascular Stents Market Analysis in Spain (2021-2030)
  • Figure 32: Vascular Stents Market Analysis in Russia (2021-2030)
  • Figure 33: Vascular Stents Market Analysis in Rest of Europe (2021-2030)
  • Figure 34: Vascular Stents Market Analysis in Asia-Pacific (2021-2030)
  • Figure 35: Vascular Stents Market Analysis in Asia-Pacific by Product Type (2021-2030)
  • Figure 36: Vascular Stents Market Analysis in Asia-Pacific by Type (2021-2030)
  • Figure 37: Vascular Stents Market Analysis in Asia-Pacific by Material (2021-2030)
  • Figure 38: Vascular Stents Market Analysis in Asia-Pacific by Mode of Delivery (2021-2030)
  • Figure 39: Vascular Stents Market Analysis in Asia-Pacific by End User (2021-2030)
  • Figure 40: Vascular Stents Market Analysis in Asia-Pacific by Country (2021-2030)
  • Figure 41: Vascular Stents Market Analysis in China (2021-2030)
  • Figure 42: Vascular Stents Market Analysis in Japan (2021-2030)
  • Figure 43: Vascular Stents Market Analysis in India (2021-2030)
  • Figure 44: Vascular Stents Market Analysis in Australia (2021-2030)
  • Figure 45: Vascular Stents Market Analysis in South Korea (2021-2030)
  • Figure 46: Vascular Stents Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Figure 47: Vascular Stents Market Analysis in Rest of World (2021-2030)
  • Figure 48: Vascular Stents Market Analysis in Rest of World by Product Type (2021-2030)
  • Figure 49: Vascular Stents Market Analysis in Rest of World by Type (2021-2030)
  • Figure 50: Vascular Stents Market Analysis in Rest of World by Material (2021-2030)
  • Figure 51: Vascular Stents Market Analysis in Rest of World by Mode of Delivery (2021-2030)
  • Figure 52: Vascular Stents Market Analysis in Rest of World by End User (2021-2030)
  • Figure 53: Vascular Stents Market Analysis in Rest of World by Country (2021-2030)
  • Figure 54: Vascular Stents Market Analysis in the Middle East (2021-2030)
  • Figure 55: Vascular Stents Market Analysis in Africa (2021-2030)
  • Figure 56: Vascular Stents Market Analysis in South America (2021-2030)
  • Figure 57: Market Drivers
  • Figure 58: Market Barriers
  • Figure 59: Market Opportunities
  • Figure 60: PORTER's Five Force Analysis